Meanwhile, share in Eli Lilly rose Monday after it announced positive news for a Phase 3 clinical program evaluating weight-loss pill Foundayo for obstructive sleep apnea.
Investors are busy trying to figure how the Democrats’ priorities will affect major industries such as banking, health care, energy, defense and the AI and data center wing of the technology sector.